Ketchum John B — SEC insider filings

SEC reporting owner CIK 1991806. 5 insider filings on record with FilingPulse; latest filed 2026-11-19.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2023-08-31 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Tango Therapeutics, Inc. (TNGX)Director5—1 leg · 3,333 sh · $80,2598

Insider filings — Ketchum John B

FiledFormIssuerReported transactionsSource
2026-11-194Tango Therapeutics, Inc. (TNGX)Sale (S): 3,333 @ $24.08EDGAR
2026-06-084Tango Therapeutics, Inc. (TNGX)Grant/award (A): 4,000 @ $0 · Grant/award (A): 25,000 (derivative) @ $0EDGAR
2025-06-094Tango Therapeutics, Inc. (TNGX)Grant/award (A): 6,250 @ $0 · Grant/award (A): 37,500 (derivative) @ $0EDGAR
2024-06-074Tango Therapeutics, Inc. (TNGX)Grant/award (A): 4,687 @ $0 · Grant/award (A): 28,125 (derivative) @ $0EDGAR
2023-08-314Tango Therapeutics, Inc. (TNGX)Grant/award (A): 10,000 @ $0 · Grant/award (A): 60,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1991806 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs